Evans Jodi F, Shen Chwan-L, Pollack Simcha, Aloia John F, Yeh James K
Department of Medicine, Winthrop University Hospital, Mineola, New York 11501, USA.
Endocrinology. 2005 Jul;146(7):3123-32. doi: 10.1210/en.2004-1612. Epub 2005 Mar 31.
Both clinical and in vitro evidence points to the involvement of the melanocortin peptide, ACTH, in the terminal differentiation of chondrocytes. Terminal differentiation along the endochondral pathway is responsible for linear growth, but also plays a role in osteoarthritic cartilage degeneration. Chondrocyte terminal differentiation is associated with an incremental increase in chondrocyte basal intracellular free calcium (Ca(2+)), and ACTH agonism of melanocortin receptors is known to mobilize Ca(2+) Using differentiated resting chondrocytes highly expressing type II collagen and aggrecan, we examined the influence of both ACTH and dexamethasone treatment on matrix gene transcription and Ca(2+). Resting chondrocytes treated concurrently with dexamethasone and ACTH expressed matrix gene transcripts in a pattern consistent with that of rapid terminal differentiation. Using the fluorescent Ca(2+) indicator, fura-2, we determined that ACTH evokes transient increases in Ca(2+) and elevates basal Ca(2+) levels in resting chondrocytes. The transient increases were initiated intracellularly, were abrogated by the phospholipase C-specific inhibitor, U73122, and were partly attenuated by myo-inositol 1,4,5-triphosphate receptor inhibition via 10 mm caffeine. The initial intracellular release also resulted in store-operated calcium entry, presumably through store-operated channels. Dexamethasone priming increased both the initial ACTH-evoked Ca(2+) release and the subsequent store-operated calcium entry. These data demonstrate roles for ACTH and glucocorticoid in the regulation of chondrocyte terminal differentiation. Because the actions of ACTH are mediated through known G protein-coupled receptors, the melanocortin receptors, these data may provide a new therapeutic target in the treatment of growth deficiencies and cartilage degeneration.
临床和体外实验证据均表明,促肾上腺皮质激素(ACTH)这种促黑素细胞肽参与软骨细胞的终末分化。软骨内成骨途径的终末分化不仅负责线性生长,还在骨关节炎软骨退变中起作用。软骨细胞终末分化与软骨细胞基础细胞内游离钙(Ca(2+))的逐渐增加有关,已知促黑素受体的ACTH激动作用可动员Ca(2+)。我们使用高度表达II型胶原蛋白和聚集蛋白聚糖的分化静止软骨细胞,研究了ACTH和地塞米松处理对基质基因转录和Ca(2+)的影响。同时用地塞米松和ACTH处理的静止软骨细胞表达的基质基因转录本模式与快速终末分化一致。使用荧光钙指示剂fura-2,我们确定ACTH可引起静止软骨细胞中Ca(2+)的短暂增加并提高基础钙水平。短暂增加始于细胞内,被磷脂酶C特异性抑制剂U73122消除,并通过10 mM咖啡因对肌醇1,4,5-三磷酸受体的抑制作用而部分减弱。最初的细胞内钙释放还导致了钙库操纵性钙内流,可能是通过钙库操纵性通道。地塞米松预处理增加了最初ACTH引起的Ca(2+)释放以及随后的钙库操纵性钙内流。这些数据证明了ACTH和糖皮质激素在软骨细胞终末分化调节中的作用。由于ACTH的作用是通过已知的G蛋白偶联受体即促黑素受体介导的,这些数据可能为生长缺陷和软骨退变的治疗提供新的治疗靶点。